CXCL12 mediates glioblastoma resistance to radiotherapy in the subventricular zone

BACKGROUND. Patients with glioblastoma (GBM) have an overall median survival of 15 months despite multimodal therapy. These catastrophic survival rates are to be correlated to systematic relapses that might arise from remaining glioblastoma stem cells (GSCs) left behind after surgery. In this line,...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Goffart, Nicolas, Lombard, Arnaud, Lallemand, François, Kroonen, Jérôme, Nassen, Jessica, Di Valentin, Emmanuel, Berendsen, Sharon, Dedobbeleer, Matthias, Willems, Estelle, Robe, Pierre, Bours, Vincent, Martin, Didier, Martinive, Philippe, Maquet, Pierre, Rogister, Bernard
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2017
Teme:
Basic and Translational Investigations
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5193023/
https://ncbi.nlm.nih.gov/pubmed/27370398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now136
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki